Literature DB >> 16078053

FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure.

Karla L Bretherick1, Margo R Fluker, Wendy P Robinson.   

Abstract

Premature ovarian failure (POF) is the occurrence of menopause before the age of 40 and affects 1% of the female population. Whereas the etiology of POF is largely unexplained, FMR1 premutation carriers are known to be at increased risk of POF compared with the general population. The FMR1 premutation alleles have 55-200 copies of a CGG repeat in the 5' untranslated region of the FMR1 gene. However, functional effects on gene expression may occur even for repeat sizes in what has been considered the "normal" range. To evaluate the role of the FMR1 repeat in POF, repeat sizes were examined in 53 women with idiopathic POF, 161 control women from the general population, and 21 women with proven fertility at an advanced maternal age. A significant increase in the number of FMR1 alleles between and including 35 and 54 CGG repeats was found in the POF patient population; 15 of 106 (14.2%) POF alleles were between and including 35 and 54 repeats, whereas only 21 of 322 (6.5%) alleles in the general population (P=0.02) and 2 of 42 (4.8%) alleles from women with proven late fertility (P=0.09) were of this size (P=0.01 versus combined controls). The effect was also significant for comparisons of genotype repeat size (repeat size weighted by the relative activity of the two FMR1 alleles) and biallelic mean (average size of the two alleles). These results are clinically relevant and suggest that the FMR1 gene plays a more significant role in the incidence of POF than has previously been thought.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078053     DOI: 10.1007/s00439-005-1326-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  41 in total

Review 1.  Premature ovarian failure and the FMR1 gene.

Authors:  A Murray
Journal:  Semin Reprod Med       Date:  2000       Impact factor: 1.303

2.  The dynamics of X-inactivation skewing as women age.

Authors:  C Hatakeyama; C L Anderson; C L Beever; M S Peñaherrera; C J Brown; W P Robinson
Journal:  Clin Genet       Date:  2004-10       Impact factor: 4.438

3.  High-throughput analysis of fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis.

Authors:  L A Larsen; K Grønskov; B Nørgaard-Pedersen; K Brøndum-Nielsen; L Hasholt; J Vuust
Journal:  Hum Genet       Date:  1997-10       Impact factor: 4.132

4.  FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Flora Tassone; Christine Iwahashi; Paul J Hagerman
Journal:  RNA Biol       Date:  2004-07-17       Impact factor: 4.652

5.  Clinical involvement and protein expression in individuals with the FMR1 premutation.

Authors:  F Tassone; R J Hagerman; A K Taylor; J B Mills; S W Harris; L W Gane; P J Hagerman
Journal:  Am J Med Genet       Date:  2000-03-13

6.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.

Authors:  Rob Willemsen; Marianne Hoogeveen-Westerveld; Surya Reis; Joan Holstege; Lies-Anne W F M Severijnen; Ingeborg M Nieuwenhuizen; Mariette Schrier; Leontine van Unen; Flora Tassone; Andre T Hoogeveen; Paul J Hagerman; Edwin J Mientjes; Ben A Oostra
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

7.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

8.  RNA leaching of transcription factors disrupts transcription in myotonic dystrophy.

Authors:  A Ebralidze; Y Wang; V Petkova; K Ebralidse; R P Junghans
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

Review 9.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

10.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

View more
  59 in total

1.  Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.

Authors:  Deborah Hall; Flora Tassone; Olga Klepitskaya; Maureen Leehey
Journal:  Mov Disord       Date:  2011-12-11       Impact factor: 10.338

2.  Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus.

Authors:  J Kline; A Kinney; S Brown; B Levin; K Oppenheimer; D Warburton
Journal:  Hum Reprod       Date:  2012-04-06       Impact factor: 6.918

Review 3.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

Review 4.  The impact of FMR1 gene mutations on human reproduction and development: a systematic review.

Authors:  Vincenzo Noto; Conor Harrity; David Walsh; Kevin Marron
Journal:  J Assist Reprod Genet       Date:  2016-07-18       Impact factor: 3.412

5.  FMR1 genotype interacts with parenting stress to shape health and functional abilities in older age.

Authors:  Marsha Mailick; Jinkuk Hong; Jan Greenberg; Leann Smith Dawalt; Mei Wang Baker; Paul J Rathouz
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-04-13       Impact factor: 3.568

6.  Prevalence of CGG expansions of the FMR1 gene in a US population-based sample.

Authors:  Marsha Mailick Seltzer; Mei Wang Baker; Jinkuk Hong; Matthew Maenner; Jan Greenberg; Daniel Mandel
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-22       Impact factor: 3.568

7.  The FMR1 CGG repeat test is not a candidate prescreening tool for identifying women with a high probability of being carriers of BRCA mutations.

Authors:  Maria Teresa Ricci; Loredana Pennese; Viviana Gismondi; Chiara Perfumo; Marina Grasso; Elena Gennaro; Paolo Bruzzi; Liliana Varesco
Journal:  Eur J Hum Genet       Date:  2013-09-25       Impact factor: 4.246

8.  Molecular Characterization of FMR1 Gene by TP-PCR in Women of Reproductive Age and Women with Premature Ovarian Insufficiency.

Authors:  Deepika Delsa Dean; Sarita Agarwal; Deepa Kapoor; Kuldeep Singh; Chandra Vati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

9.  Screening for intermediate CGG alleles of FMR1 gene in male Iranian patients with Parkinsonism.

Authors:  Atefeh Entezari; Mahmoud Shekari Khaniani; Tayyeb Bahrami; Sima Mansoori Derakhshan; Hossein Darvish
Journal:  Neurol Sci       Date:  2016-10-01       Impact factor: 3.307

10.  Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers?

Authors:  M Friedman-Gohas; M Kirshenbaum; A Michaeli; N Domniz; S Elizur; H Raanani; R Orvieto; Y Cohen
Journal:  J Assist Reprod Genet       Date:  2020-02-24       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.